The Standard Group Plc is a multi-media organization with investments in media platforms spanning newspaper print
operations, television, radio broadcasting, digital and online services. The Standard Group is recognized as a
leading multi-media house in Kenya with a key influence in matters of national and international interest.
It has been a race like no other. Since December last year when the first cases of coronavirus were reported in Wuhan, China, researchers, drug makers and strategists in the medical field have been working hours on end to find a cure or vaccine that will thwart the virus that keeps growing.
Some researchers are focusing on tried and tested antivirals that have worked for other diseases. Others have partnered with big pharmaceuticals to come up with new trials. There is a global solidarity trial currently underway, with Kenya being one of the countries that have been approved to participate.
The question of whether there will be a cure, and how soon it will be available is one that lingers in global conversations.
Nobody knows the solid answer, but from the list of global tests and trials presented below, the world could be inching closer to defeating the virus.
“There are so many treatments under development, it’s hard to keep up. I never looked at it to grow this big, this fast, and I’ve worked on all different therapeutic areas from Alzheimer’s to cancer, and to see a pipeline of this size and this breadth is amazing,” says David Thomas, vice president of Industry Research at BIO which is a trade association representing the biotechnology industry.
There have also been searches for vaccines that will prevent people who have not got the virus from contracting it.
The closest we are towards getting a vaccine is early 2021, and researchers suggest that antibody treatment could be got before the year ends. Some of the treatments under study are; Convalenscent plasma, Dexamethasone, Chloroquine and Azithromycin, Remdesivir, Raivant, Danoprevir, Pfizer and Stem cell therapies.
join